Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms

Despite the emergence of JAK inhibitors, there is a need for disease-modifying treatments for Philadelphia-negative myeloproliferative neoplasms (MPNs). JAK inhibitors ameliorate symptoms and address splenomegaly, but because of the heterogeneous contributors to the disease process, JAK inhibitor mo...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:EBioMedicine
मुख्य लेखकों: Kaplan, Jason B., Stein, Brady L., McMahon, Brandon, Giles, Francis J., Platanias, Leonidas C.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Elsevier 2016
विषय:
Review
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4739416/
https://ncbi.nlm.nih.gov/pubmed/26870834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2016.01.010
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन